Published on 17 Oct 2024 on GuruFocus.com · via Yahoo Finance
State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings
Overview of Recent Transaction
On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining stake of 896,123 shares. This move reflects a strategic adjustment in State Street Corp's investment portfolio, despite the trade having a minimal immediate impact on its overall position.
State Street Corp: Investment Philosophy and Profile